MainBoardListed
Sudeep Pharma Limited
Company websiteSubscription runs from 21-11-2025 to 25-11-2025, with allotment expected on 26-11-2025.
Sudeep Pharma Limited is seeking ₹1,50,92,749 crore — a fresh issue of ₹16,02,024 crore plus OFS of ₹1,34,90,726 crore. Expect market interest to determine final listing performance.
Start Date21-11-2025
End Date25-11-2025
Listing Date28-11-2025
Allotment Date26-11-2025
Current Price₹737
GMP₹94 (15.85%)
Lot Size25 Shares
Subscription93.72 Times
Face Value₹1 Per Share
Listing atNSE, BSE
Issue Price₹563 - ₹593
Pre Issue₹11,13,46,602
Post Issue₹11,29,48,626
Issue Size₹1,50,92,749
(aggregating up to 895.00 Cr)
(aggregating up to 895.00 Cr)
Fresh Issue₹16,02,024
(aggregating up to 95.00 Cr)
(aggregating up to 95.00 Cr)
Offer For Sale₹1,34,90,726
(aggregating up to 800.00 Cr)
(aggregating up to 800.00 Cr)
The Grey Market Premium (GMP) for Sudeep Pharma Limited is currently around ₹94 (15.85%). This indicates an estimated listing price of approximately ₹657 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.
Gmp Details
| Last Updated | IPO Price | GMP | Estimated Listing Price |
|---|---|---|---|
27 Nov 2025, 13:32 | ₹593 | ₹94 | ₹687 (15.85%) |
26 Nov 2025, 08:28 | ₹593 | ₹84 | ₹677 (14.17%) |
25 Nov 2025, 11:23 | ₹593 | ₹70 | ₹663 (11.80%) |
24 Nov 2025, 12:50 | ₹593 | ₹64 | ₹657 (10.79%) |
23 Nov 2025, 13:25 | ₹593 | ₹102 | ₹695 (17.20%) |
21 Nov 2025, 08:32 | ₹593 | ₹94 | ₹687 (15.85%) |
20 Nov 2025, 15:39 | ₹593 | ₹101 | ₹694 (17.03%) |
19 Nov 2025, 11:28 | ₹593 | ₹103 | ₹696 (17.37%) |
18 Nov 2025, 10:22 | ₹593 | ₹45 | ₹638 (7.59%) |
17 Nov 2025, 11:01 | ₹593 | ₹0 | ₹593 (0.00%) |
Financials overview In Crores
Here is a quick look at the recent financial performance of Sudeep Pharma Limited . The numbers below ( In Crores ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.
Key Performance
| KPI | Jun-25 | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|---|
EPS | 0 | 0 | 0 | 0 |
ROE | 4.52 | 28.13 | 37.41 | 27.91 |
ROCE | 5.50 | 29.82 | 41.17 | 29.40 |
RONW | 0 | 0 | 0 | 0 |
PRE IPO(PE) | 0 | 47.61 | 0 | 0 |
POST IPO(PE) | 53.55 | 0 | 0 | 0 |
Subscription Details (No. of Shares)
The below shows how many shares were subscribed by each investor category in the Sudeep Pharma Limited IPO. These numbers help you understand where the demand is coming from – whether it’s retail investors, QIBs, or NIBs. Higher subscription usually indicates strong interest and confidence from the market.
Subscription Demand (in ₹ Crore)
| Category | Offered | Demand | Times |
|---|---|---|---|
QIBs | ₹179 | 38141.08 | 213.08 |
FIIs | ₹0 | 11221.95 | 0.00 |
FIs | ₹0 | 15279.16 | 0.00 |
Mutual Funds | ₹0 | 1698.7 | 0.00 |
Others | ₹0 | 9941.26 | 0.00 |
RETAIL | ₹313.25 | 4902.41 | 15.65 |
HNIs 2+ | ₹44.75 | 3594.84 | 80.33 |
HNIs 10+ | ₹89.50 | 12074.65 | 134.91 |
Total | ₹626.50 | 58712.98 | 93.72 |
Application Wise Breakup (Approx. no of Apps)
| Category | Reserved | Applied | Times |
|---|---|---|---|
RETAIL | 2,11,298 | 27,22,863 | 12.89 |
HNIs(10L +) | 4,312 | 1,17,655 | 27.29 |
HNIs (2-10L) | 2,156 | 1,64,607 | 76.35 |
Total | 2,17,766 | 30,05,125 | 13.80 |
The IPO reservation for Sudeep Pharma Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.
IPO Reservation
| Category | Shares Offers | No. of Shares |
|---|---|---|
Anchor | 30.00% | 45,27,823 |
QIB | 20.00% | 30,18,553 |
HNI | 15.00% | 22,63,912 |
RETAIL | 35.00% | 52,82,462 |
TOTAL | 100.00% | 1,50,92,750 |
Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
Retail | 1 | 25 | ₹14,825 | |
sHNI | 14 | 350 | ₹2,07,550 | |
bHNI | 68 | 1,700 | ₹10,08,100 |
Below you can find the official contact details of Sudeep Pharma Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.
Company Details
Email: cs.sudeep@sudeepgroup.com
Phone: +91 265 284 0656
Website: https://www.sudeeppharma.com/
Address: 129/1/A, GIDC Estate, Nandesari, Vadodara, Gujarat, 391340
IPO Registrar
Name: Link Intime India Private Limited
Phone: +91-22-4918 6270